Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > BMRA

<< Previous

Bullboard Posts

Next >>

Comment by EduardoSanchezon Mar 19, 2020 9:36pm

66 Views

Post# 30828897

RE:RE:RE:RE:RE:BMRA

Absolute Apples to Oranges and no comparison to PCR.

These are antibody tests , there are many other companies making these now. These are a dime a dozen nothing disruptive at all. There is a big difference from a RT-PCR and an antibody test for a highly contagious virus. There is a reason PCR is the gold standard.

This is from Jack:
“Please see attachment. Antibody tests are only good long after the acute phase of the infection…after the patient has infected all his/her friends family. IgM comes up first about 13 days after viral exposure, and they can only detect 87%….they have to wait for 20 days to get a better detection rate”.

This is why RT-PCR (what LexaGene does) is preferred. RT-PCR can detect covid 1-2 days before symptoms and as early as 2 days after exposure.